Pharma R&D Today

The Future of Chemistry R&D Will Depend on Deep Learning

Posted on June 7th, 2018 by Matthew Clark

A recent survey of chemists, carried out by Elsevier’s Reaxys team, showed that only 13% identified a familiarity with machine learning (or similar technologies) as being important for future chemists. Continue reading “The Future of Chemistry R&D Will Depend on Deep Learning” »

Cancer-killing combo: Viagra and the flu vaccine

Posted on June 6th, 2018 by Christy J. Wilson

“Strange bedfellows” doesn’t even begin to describe the drug combination that a new study published in OncoImmunology suggests may actually work together to combat cancer. Continue reading “Cancer-killing combo: Viagra and the flu vaccine” »

When Looking to Accelerate the Pace of Research, Having the Right Multidisciplinary Tools Matters

Posted on May 18th, 2018 by Christy J. Wilson

Have you ever heard the term “stay in your lane”? While it may be applicable in some workplaces, where people are expected to keep their focus narrow, these days it isn’t something you’ll hear much in pharmaceutical-related industries. Continue reading “When Looking to Accelerate the Pace of Research, Having the Right Multidisciplinary Tools Matters” »

Big Talks on Big Data are Coming to Bio IT World

Posted on May 9th, 2018 by Neal Katz

At next week’s Bio IT World conference and expo (Boston, May 15-17), Elsevier will be giving four talks on the implications of AI and machine learning on life science research, a statistical analysis of concordance between animal toxicities and human adverse events, strategies for increasing data sharing and the latest technologies being used to integrate multiple data sources. Continue reading “Big Talks on Big Data are Coming to Bio IT World” »

Drug Makers Seek to Shorten the Flu with New Treatments

Posted on April 2nd, 2018 by Christy J. Wilson

This flu season, which has peaked but isn’t over quite yet, has been particularly brutal. Last month, NBC News reported that it was already on track to be as bad as the H1N1 swine flu pandemic in 2009. Continue reading “Drug Makers Seek to Shorten the Flu with New Treatments” »

Can Wearables Improve Employee Health?

Posted on March 27th, 2018 by Tim Hoctor

At first glance, companies using wearables, such as Fitbits, as a way of encouraging health and wellness among employees may seem like a great idea. Healthier workers are typically happier workers, Continue reading “Can Wearables Improve Employee Health?” »

About this Blog

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.